急性 COVID-19 感染后双侧急性虹膜退色（BADI）和双侧急性虹膜透光（BAIT）。
Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)Following Acute COVID-19 Infection.
机构信息
Beyoglu Eye Training and Research Hospital, University of Health Sciences Turkey, Istanbul, Turkey.
Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
出版信息
Ocul Immunol Inflamm. 2023 Aug;31(6):1163-1168. doi: 10.1080/09273948.2022.2103832. Epub 2022 Sep 9.
PURPOSE
To report the presenting features and outcomes in patients who developed bilateral acute iris transillumination (BAIT) or bilateral acute depigmentation of iris (BADI) following acute COVID-19 infection.
METHODS
Thirty two eyes of 16 patients were reviewed retrospectively. The severity of COVID-19 infection, use of antibiotics, time of onset of ocular symptoms; ocular signs, the course and surgical procedures were recorded.
RESULTS
24 eyes of 12 BAIT and eight eyes of four consecutive BADI patients were included. The mean time between infection and onset of ocular symptoms was 2.5±1.1 weeks. Nine patients were treated with oral moxifloxacin for COVID-19 prior to presentation. Trabeculectomy was performed in 7 eyes (21.8%) of 5 BAIT patients; in the postoperative follow-up, IOP was controlled without medication in 6 eyes, with medication in 1 eye.
CONCLUSION
BADI and BAIT can also develop after COVID-19 infection. A significant proportion of BAIT patients may require glaucoma surgery.
目的
报告急性 COVID-19 感染后发生双侧急性虹膜透照（BAIT）或双侧急性虹膜色素脱失（BADI）的患者的临床表现和结局。
方法
回顾性分析了 16 名患者的 32 只眼。记录了 COVID-19 感染的严重程度、抗生素的使用、眼部症状出现的时间；眼部体征、病程和手术过程。
结果
纳入 12 例 BAIT 的 24 只眼和 4 例连续 BADI 患者的 8 只眼。感染与眼部症状出现之间的平均时间为 2.5±1.1 周。9 名患者在就诊前因 COVID-19 口服莫西沙星。5 例 BAIT 患者中有 7 只眼（21.8%）行小梁切除术；术后随访，6 只眼眼压控制无需药物治疗，1 只眼需药物治疗。
结论
COVID-19 感染后也可发生 BADI 和 BAIT。相当一部分 BAIT 患者可能需要青光眼手术。
Zotero 插件